Skip to main content
HairCited

Spironolactone الأشكال

5 أشكال من أبحاث محكّمة

الكل Dutasteride Finasteride L-Cysteine Minoxidil MSM Spironolactone أحماض أوميغا-3 الدهنية الحديد الزنك السيلينيوم العلاج بالبلازما الغنية بالصفائح الدموية العلاج بالليزر منخفض المستوى الكافيين (موضعي) الكولاجين الكيراتين الوخز بالإبر الدقيقة زيت إكليل الجبل فيتامين B12 فيتامين D
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig. 5. Summary of evidence for the use of combination treatment of topical minoxidil in male and female androgenetic alopecia (Varothai and Bergfeld, 2014)
Figure 7

A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Figure 3
Figure 3

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 4
Figure 4

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 5
Figure 5

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.
Figure 6

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …